| P50 | author | Alex Sparreboom | Q71780219 |
| | Jaap Verweij | Q98683725 |
| P2093 | author name string | Keiji Tanimoto | |
| | Ryo Okamoto | |
| | Masahiko Nishiyama | |
| | Wataru Yamamoto | |
| | Tatsunori Okamura | |
| | Takashi Sekikawa | |
| | Hiroshi Takano | |
| | Ji-Seon Park | |
| P2860 | cites work | A multidrug resistance transporter from human MCF-7 breast cancer cells | Q22008574 |
| | Isolation and structural characterization of a cDNA clone encoding the human DNA repair protein for O6-alkylguanine | Q24336908 |
| | p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents | Q28579401 |
| | Suppression of human colorectal carcinoma cell growth by wild-type p53 | Q29618318 |
| | Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humans | Q33179201 |
| | Structure, Function, and Inhibition of O6-Alkylguanine-DNA Alkyltransferase | Q40473972 |
| | The current status of camptothecin analogues as antitumor agents | Q40851253 |
| | Characterization of a human small-cell lung cancer cell line resistant to a new water-soluble camptothecin derivative, DX-8951f | Q40978962 |
| | The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitro | Q41064018 |
| | Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma | Q41090576 |
| | DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant | Q41094672 |
| | Molecular targeting of mitomycin C chemotherapy | Q41094677 |
| | Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity. | Q41448559 |
| | An overview of the clinical pharmacology of topotecan | Q41448813 |
| | Differential inactivation of O6-methylguanine-DNA methyltransferase activity by O6-arylmethylguanines. | Q54162250 |
| | A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo. | Q54167076 |
| | NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy. | Q55476248 |
| | Measurement of O6-alkylguanine-DNA alkyltransferase activity in human cells and tumor tissues by restriction endonuclease inhibition | Q69811351 |
| | Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity | Q77973119 |
| P433 | issue | 1 | |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 93-102 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Japanese Journal of Cancer Research | Q26842384 |
| P1476 | title | O(6)-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives | |
| P478 | volume | 93 | |